Intensive Care Patients from the First COVID-19 Wave: One-Year Survival after Tocilizumab Treatment
Introduction: An infection by COVID-19 triggers a dangerous cytokine storm, so tocilizumab has been introduced in Italy as an agent blocking the cytokine storm. This paper aims to describe the one-year survival of ICU patients treated with tocilizumab. Methods: This observational study enrolled all...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
MDPI AG
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/60a55ff4f2da4522a9a232afed5a43c3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|